Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis.
- 2026-06-03
- Review · n = 809
- Neuropsychiatric disease and treatment 22
- Rakesh Kumar
- Zahra Hashempour
- Sara Shahriarirad
- Reza Shahriarirad
- Leslie C Hassett
- Balwinder Singh
- Paul E Croarkin
- Marin Veldic
- Mark A Frye
- Sandeep R Pagali
- PubMed: 42261369
- DOI: 10.2147/ndt.s586506
- High evidence
- Clinical
meta-analysis (n=10) studies (14 randomized controlled trials [RCTs] and 1 open label) involving 809 participants ... revealed that ALC significantly reduces depressive symptoms compared to placebo, with comparable efficacy to standard antidepressants and fewer adverse effects.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes